A UK general practice population cohort study investigating the association between lipid lowering drugs and 30-day mortality following medically attended acute respiratory illness
Background. Cholesterol lowering drugs HMG-CoA reductase inhibitors (statins) and PPARα activators (fibrates) have been shown to reduce host inflammation via non-disease specific immunomodulatory mechanisms. Recent studies suggest that commonly prescribed drugs in general practice, statins and fibra...
Main Authors: | Roshni Joshi, Sudhir Venkatesan, Puja R. Myles |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2016-04-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/1902.pdf |
Similar Items
-
Elucidating the Effects of the Lipids Regulators Fibrates and Statins on the Health Status of Finfish Species: A Review
by: Manuel Blonç, et al.
Published: (2023-02-01) -
AUTOIMMUNE DISEASES AND ATHEROSCLEROSIS - PROBLEMS OF TREATMENT
by: I. V. Shirinskiy, et al.
Published: (2012-05-01) -
Zebrafish as a Model for the Study of Lipid-Lowering Drug-Induced Myopathies
by: Magda Dubińska-Magiera, et al.
Published: (2021-05-01) -
Assessment of the global and national market for lipid modifying agents: retrospective and innovation
by: A. V. Lokhmacheva, et al.
Published: (2023-08-01) -
Mediterranean Diet and Physical Activity Decrease the Initiation of Cardiovascular Drug Use in High Cardiovascular Risk Individuals: A Cohort Study
by: Margarita Ribó-Coll, et al.
Published: (2021-03-01)